Drug Type Small molecule drug |
Synonyms Mylis, Prasterone vaginal, Sodium Prasterone Sulfate + [7] |
Target |
Action agonists |
Mechanism AR agonists(Androgen Receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC19H28NaO5S |
InChIKeyLCLCCCKZRQRRTC-ZJTJBYBXSA-N |
CAS Registry1099-87-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Prasterone Sodium Sulfate Hydrate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Labor, Induced | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Vaginal Diseases | Phase 3 | China | 13 Oct 2016 |